Pharmaceutical composition used for treating cold and cough and capable of activating blood circulation to dissipate blood stasis, and preparation method thereof
A technology for promoting blood circulation and removing blood stasis and a composition is applied in the field of pharmaceutical compositions for treating colds and coughs and promoting blood circulation and removing blood stasis and the field of preparation thereof, which can solve the problems of chronic cough without effective therapeutic effect, slow treatment process, repeated attacks, etc. Significant curative effect, short healing time, not easy to repeat
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0042] Embodiment 1: Powder
[0043] The raw materials for the preparation of the pharmaceutical composition of Example 1 of the present invention include: 10 parts of P. chinensis extract, 18 parts of pseudophysalis, 10 parts of Zangyehua, 2 parts of periwinkle, 15 parts of Nigella, 3 parts of Herb 5 parts of indigo, 10 parts of aster, 8 parts of basil, 12 parts of marshmallow root, 6 parts of bellflower, 3 parts of northern bean root, 6 parts of lycopodium, 6 parts of wasp orange, 7 parts of mulberry leaf, 6 parts of hedyotis diffusa , 10 parts of mint and 8 parts of licorice.
[0044] The preparation method is as follows:
[0045] 1) Preparation of the extract of P. chinensis: Weigh the root of P. chinensis, crush it, add distilled water 4 times the initial weight, then soak for 35 minutes, reflux and decoct twice for 1 hour, filter to obtain the filtrate, and depressurize Dried, crushed and passed through a 100-mesh sieve to obtain the extract of P. chinensis;
[0046] ...
Embodiment 2
[0053] Embodiment 2: powder
[0054] The raw materials for the preparation of the pharmaceutical composition of Example 2 of the present invention include: 20 parts of P. chinensis extract, 25 parts of pseudophysalis, 18 parts of Zangyehua, 5 parts of periwinkle, 20 parts of Nigella, 6 parts of Herb 8 parts of indigo, 15 parts of aster, 12 parts of lily, 16 parts of marshmallow root, 10 parts of bellflower root, 6 parts of northern bean root, 9 parts of lycopodium, 9 parts of wasp orange, 11 parts of mulberry leaf, 0 part of hedyotis diffusa , 12 parts of mint and 20 parts of licorice.
[0055] The preparation method is the same as in Example 1.
Embodiment 3
[0056] Embodiment 3: Powder
[0057] The raw materials for the preparation of the pharmaceutical composition of Example 3 of the present invention include: 15 parts of P. chinensis extract, 22 parts of pseudophysalis, 14 parts of Zangyehua, 4 parts of periwinkle, 18 parts of Nigella sativa, 4 parts of Herba 6 parts of indigo, 12 parts of aster, 10 parts of lily, 14 parts of marshmallow root, 8 parts of bellflower, 5 parts of northern bean root, 8 parts of lycopodium, 8 parts of wasp orange, 9 parts of mulberry leaf, and 8 parts of hedyotis diffusa , 11 parts of mint and 14 parts of licorice.
[0058] The preparation method is the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com